Lixte Biotechnology Holdings, Inc. (LIXT)

NASDAQ: LIXT · IEX Real-Time Price · USD

2.390

-0.140 (-5.53%)

At close: Jul 19, 2024, 4:00 PM

2.320

-0.070 (-2.93%)

Pre-market: Jul 20, 2024, 9:29 AM EDT

LIXT Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2006
Selling, General & Admin	2.26	2.7	3.82	3.75	2.04	1.67	Upgrade
Research & Development	0.83	0.9	1.35	1.74	1.22	0.82	Upgrade
Other Operating Expenses	1.6	1.5	1.15	1.23	0	0	Upgrade
Operating Expenses	4.69	5.09	6.31	6.72	3.27	2.49	Upgrade
Operating Income	-4.69	-5.09	-6.31	-6.72	-3.27	-2.49	Upgrade
Interest Expense / Income	0.02	0.02	0.01	0.01	0	0	Upgrade
Other Expense / Income	-0.02	-0.02	-0.01	0	-0.01	-0.05	Upgrade
Pretax Income	-4.69	-5.09	-6.31	-6.73	-3.26	-2.44	Upgrade
Net Income	-4.69	-5.09	-6.31	-6.73	-3.26	-2.44	Upgrade
Shares Outstanding (Basic)	2	2	2	1	1	1	Upgrade
Shares Outstanding (Diluted)	2	2	2	1	1	1	Upgrade
Shares Change	35.10%	21.10%	17.41%	19.48%	0.92%	14.04%	Upgrade
EPS (Basic)	-2.33	-2.66	-3.99	-5.00	-2.90	-2.20	Upgrade
EPS (Diluted)	-2.33	-2.66	-3.99	-5.00	-2.90	-2.20	Upgrade
Free Cash Flow	-3.81	-4.29	-4.61	-4.14	-2.13	-1.67	Upgrade
Free Cash Flow Per Share	-1.69	-2.24	-2.92	-3.08	-1.89	-1.50	Upgrade
EBITDA	-4.67	-5.07	-6.3	-6.72	-3.26	-2.44	Upgrade
EBIT	-4.67	-5.07	-6.3	-6.72	-3.26	-2.44	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).